Esteban Rodriguez
Overview
Explore the profile of Esteban Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelnabi R, Perez P, Astorgano D, Albericio G, Kerstens W, Thibaut H, et al.
Front Immunol
. 2023 Nov;
14:1163159.
PMID: 37920464
The development of novel optimized vaccines against coronavirus disease 2019 (COVID-19) that are capable of controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the appearance of different...
2.
Esteso G, Felgueres M, Garcia-Jimenez A, Reyburn-Vales C, Benguria A, Vazquez E, et al.
Oncoimmunology
. 2022 Dec;
12(1):2160094.
PMID: 36567803
Bacillus Calmette-Guérin (BCG), the nonpathogenic strain used as tuberculosis vaccine, has been successfully used as treatment for non-muscle invasive bladder cancer for decades, and suggested to potentiate cellular and humoral...
3.
Moreo E, Uranga S, Pico A, Gomez A, Nardelli-Haefliger D, Del Fresno C, et al.
J Immunother Cancer
. 2022 Jul;
10(7).
PMID: 35781395
Background: Intravesical BCG is the gold-standard therapy for non-muscle invasive bladder cancer (NMIBC); however, it still fails in a significant proportion of patients, so improved treatment options are urgently needed....
4.
Boudewijns R, Perez P, Lazaro-Frias A, Van Looveren D, Vercruysse T, Thibaut H, et al.
Front Immunol
. 2022 Apr;
13:845969.
PMID: 35371064
To control the coronavirus disease 2019 (COVID-19) pandemic and the emergence of different variants of concern (VoCs), novel vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed. In...
5.
Mooij P, Garcia-Arriaza J, Perez P, Lazaro-Frias A, Verstrepen B, Boszormenyi K, et al.
Front Immunol
. 2022 Apr;
13:845887.
PMID: 35371043
Novel safe, immunogenic, and effective vaccines are needed to control the COVID-19 pandemic, caused by SARS-CoV-2. Here, we describe the safety, robust immunogenicity, and potent efficacy elicited in rhesus macaques...
6.
Wilson E, Turner C, Sanz-Rodriguez C, Arayasirikul S, Gagliano J, Woods T, et al.
J Acquir Immune Defic Syndr
. 2021 Nov;
88(S1):S39-S48.
PMID: 34757991
Background: Pre-exposure prophylaxis (PrEP) uptake among trans people to date has been low. Recommendations implemented in San Francisco to offer PrEP with feminizing hormones have not led to improvement of...
7.
Dijkman K, Aguilo N, Boot C, Hofman S, Sombroek C, Vervenne R, et al.
Cell Rep Med
. 2021 Feb;
2(1):100187.
PMID: 33521701
To fight tuberculosis, better vaccination strategies are needed. Live attenuated -derived vaccine, MTBVAC, is a promising candidate in the pipeline, proven to be safe and immunogenic in humans so far....
8.
Vierboom M, Dijkman K, Sombroek C, Hofman S, Boot C, Vervenne R, et al.
Cell Rep Med
. 2021 Feb;
2(1):100185.
PMID: 33521699
BCG vaccination can strengthen protection against pathogens through the induction of epigenetic and metabolic reprogramming of innate immune cells, a process called trained immunity. We and others recently demonstrated that...
9.
White A, Sibley L, Sarfas C, Morrison A, Gullick J, Clark S, et al.
NPJ Vaccines
. 2021 Jan;
6(1):4.
PMID: 33397991
A single intradermal vaccination with MTBVAC given to adult rhesus macaques was well tolerated and conferred a significant improvement in outcome following aerosol exposure to M. tuberculosis compared to that...
10.
Aguilo N, Uranga S, Mata E, Tarancon R, Gomez A, Marinova D, et al.
Front Microbiol
. 2020 Jul;
11:1339.
PMID: 32625195
Vaccination through the natural route of infection represents an attractive immunization strategy in vaccinology. In the case of tuberculosis, vaccine delivery by the respiratory route has regained interest in recent...